EP
CLVS

Eversept Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Eversept Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$60.6K – 94
2022
Q1 		$60.6K Buy
+30,000
New +$60.6K ﹤0.01% 76
2018
Q1 		– Sell
-16,397
Closed -$1.11M – 62
2017
Q4 		$1.11M Buy
+16,397
New +$1.11M 0.64% 29